What Are Precancerous Polyps?
Precancerous polyps are abnormal growths in the colon and rectum that have the potential to transform into colorectal cancer over time if left untreated, accounting for 15-30% of all colorectal cancers. 1
Types of Precancerous Polyps
Precancerous colorectal lesions fall into two main categories 2, 3:
Non-Serrated Lesions
- Conventional adenomas (tubular, tubulovillous, and villous adenomas) - these are the most common precancerous polyps 2, 3
- These typically lead to colorectal cancers that are microsatellite stable 3
- Can occur sporadically or in hereditary adenomatous polyposis syndromes 2
Serrated Lesions
- Sessile serrated adenomas (SSLs) - the second most common type, leading to cancers with high DNA methylation 3
- Traditional serrated adenomas - the least common precancerous polyp type 3
- Some hyperplastic polyps - particularly those in the proximal colon, which were historically considered harmless but are now recognized as having malignant potential 4
Clinical Significance and Risk Factors
The transformation from polyp to cancer follows a multistep process involving histological, morphological, and genetic changes that accumulate over time 5. This slow progression is precisely why screening and early removal of these lesions can substantially decrease colorectal cancer incidence 1, 5.
Key risk determinants include 2:
- Size: Larger polyps (≥10 mm) carry higher cancer risk 1
- Histological subtype: Villous features and serrated architecture affect risk 2
- Degree of dysplasia: High-grade dysplasia indicates greater malignant potential 2
Surveillance Recommendations
For sessile serrated lesions ≥10 mm or any serrated lesions with dysplasia (including traditional serrated adenomas), a one-off colonoscopic surveillance examination at 3 years is recommended 1. This reflects their association with higher future colorectal cancer risk 1.
Important Clinical Caveat
Despite up to 50% of screening examinations detecting polyps, the lifetime colorectal cancer risk is only 3.9-4.3%, meaning most individuals with polyps would not develop cancer in their lifetime 6. This highlights the challenge of determining which polyps truly require intensive surveillance versus those that may be safely managed with less aggressive follow-up 6.